QDEL
21.01
-1.5%↓
NERV
4.3
+5.91%↑
LSTA.US
2.02
-4.72%↓
QDEL
21.01
-1.5%↓
NERV
4.3
+5.91%↑
LSTA.US
2.02
-4.72%↓
QDEL
21.01
-1.5%↓
NERV
4.3
+5.91%↑
LSTA.US
2.02
-4.72%↓
QDEL
21.01
-1.5%↓
NERV
4.3
+5.91%↑
LSTA.US
2.02
-4.72%↓
QDEL
21.01
-1.5%↓
NERV
4.3
+5.91%↑
LSTA.US
2.02
-4.72%↓
24h
Curent
Minim
111.15
Maxim
115.9
Venit | -83M 652M |
|---|---|
Vânzări | -25M 5.3B |
EPS | 2.07 |
Randament dividend | 1.34 |
Marjă de profit | 12.407 |
Recomandări | Cumpărare |
|---|---|
Prognoză pe 12 luni | +17.72% upside |
Randament dividend Medie Sector | 1.34% 2.37% |
|---|
Capitalizare de piață | 98B |
|---|---|
Deschiderea anterioară | 114.95 |
Închiderea anterioară | 111.75 |
By Acuity
24%
76%
55 / 374 Clasament în Healthcare
By Trading Central
Încredere
Strong Bearish Evidence
121.15 / 123.55 Suport & Rezistență
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
13 nov. 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Citește
13 nov. 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Citește
1 oct. 2025, 08:54 UTC
Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
DJ
Citește
13 nov. 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View
DJ
Citește
13 nov. 2025, 06:00 UTC
Analysts Saw Merck KGaA 3Q Net Sales at EUR5.23B
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.67B
DJ
Citește
13 nov. 2025, 06:00 UTC
Analysts Saw Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.56B
DJ
Citește
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q Sales EUR5.32B
DJ
Citește
6 nov. 2025, 21:52 UTC
Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED
DJ
Citește
6 nov. 2025, 21:51 UTC
Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany
DJ
Citește
16 oct. 2025, 08:34 UTC
Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk
DJ
Citește
15 oct. 2025, 12:08 UTC
Merck KGaA Didn't Disclose Financial Details
DJ
Citește
15 oct. 2025, 12:07 UTC
Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio
DJ
Citește
15 oct. 2025, 12:07 UTC
Merck KGaA: Unit is Based in Belgium, Has 50+ Employees
DJ
Citește
15 oct. 2025, 12:06 UTC
Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market
DJ
Citește
15 oct. 2025, 12:05 UTC
Merck KGaA: Definitive Agreement Signed Today
DJ
Citește
15 oct. 2025, 12:05 UTC
Merck KGaA: Transaction Expected to Close by End of 2Q 2026
DJ
Citește
15 oct. 2025, 12:04 UTC
Merck KGaA to Buy Chromatography Business JSR Life Sciences
DJ
Citește
15 oct. 2025, 12:03 UTC
Merck KGaA to Buy Chromatography Business of JSR Life Sciences
DJ
Citește
7 aug. 2025, 08:04 UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Citește
Modificare preț
By TipRanks
Prognoză pe 12 luni
Medie 138.38 EUR 17.72%
Maxim 182 EUR
Minim 105 EUR
În baza a 9 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMerck KGaA - Dist în ultimele 3 luni.
By TipRanks
Cumpărare
9 ratings
5
Cumpărare
3
Păstrare
1
Vânzare
Ținând cont de 9 analiști care au acordat evaluări ale acțiunilor Merck KGaA - Dist în ultimele 3 luni.
By Trading Central
Termen scurt
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Termen mediu
Neutral Evidence
The bullish and bearish events are balanced.
Termen lung
Bearish Evidence
All events are bearish.
By Acuity
Sentimentul știrilor
Evidențe foarte puternice de creștere
Volatilitate
Sub medie
Volumul știrilor (RCV)
Peste medie
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$